E966-0530-45418

N/A

Report date: 2023/04/17 15:25:43
NME

Base Information

Drug NameE966-0530-45418
Drug Alias NameE966-0530-45418
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 8 inhibitors
TargetsCyclin-dependent kinase 8
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Taiwan University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A